A Clinical Study Evaluating Licaminlimab for Dry Eye Disease
ConditionDry Eye Disease (DED)
Trial statusRecruiting
Trial phasePhase 2, Phase 3
Trial typeInterventional
Biological sexAll
Age18+
SponsorOculis
About this trial
The primary objective of this study is to evaluate the efficacy and safety of the topical ophthalmic administration of licaminlimab as compared to vehicle in participants with Dry Eye Disease and a specific genotype.
Eligibility criteria
Qualifiers
Physician diagnosis of Dry Eye Disease in the past 6 months
Use of over-the-counter tears
Must agree to genotype testing
Disqualifiers
None
Trial design
Treatments tested in this trial
- Artificial Tear Run-in
- licaminlimab
- Vehicle of licaminlimab
Treatment groups
160 Participants
are divided into 2 treatment groupsLocations
14California
East West Eye Institute92656, Aliso Viejo United States
Orange County Ophthalmology92843, Garden Grove United States
Global Research Management91204, Glendale United States
LoBue Laser and Eye Medical Center92562, Murrieta United States
Sponsors and collaborators
Oculis
Lead sponsor
Source ClinicalTrials.gov